Skip to content

Future Genomics Technologies B.V.

Ongoing bankruptcy

Trading as FG-tech, FG-technologies

3 financial reports
KvK
68831552
Establishment
Leiden, Zuid-Holland
Court
Den Haag
Bankruptcy number
F.09/26/121
Insolvency practitioner
mr. A.J.M. van Winden, La Gro B.V.

Summary

On April 14, 2026, the Rechtbank Den Haag declared Future Genomics Technologies B.V. bankrupt (insolvency number F.09/26/121). It is a BV from Leiden. Its KvK number is 68831552. According to the Commercial Register, its main activity is natuurwetenschappelijk onderzoek en experimentele ontwikkeling. FG-tech en FG-technologies are registered as trade names. mr. A.J.M. van Winden (La Gro B.V.) has been appointed insolvency practitioner. mr. D. de Loor has been appointed supervisory judge. There are 3 public reports; the latest is report 3 of November 12, 2026. In addition, there are 3 financial reports; the latest is financial report 3 of November 12, 2026. So far the reports have appeared on average every 92 days; the next one is therefore expected around February 12, 2027. Estate assets according to financial report 3: €66,878.38. Key figures according to report 3: unsecured claims €918.39, creditors 1 en preferential claims €77,578.08. Status according to report 3: under investigation: actio pauliana; ongoing: legal proceedings.

Zuid-Holland recorded 653 bankruptcies in the past twelve months. Of these, 21 were in the municipality of Leiden. The advisering, onderzoek en specialistische zakelijke diensten sector accounted for 19 cases in this province.

Preferential claims according to report 3 of November 12, 2026: €77,578.08 (in report 2 of August 13, 2026: €2,781).

Estate account balance according to report 3 of November 12, 2026: €65,959.48 (in report 2 of August 13, 2026: €60,199.15).

Employees according to report 3 of November 12, 2026: 4.

The company information lists Sylviusweg 74, 2333BE Leiden as a business address for Future Genomics Technologies B.V..

Submit a claim

Creditors submit their claim in writing to the insolvency practitioner, stating insolvency number F.09/26/121 and enclosing the supporting documents.

Deadline for submission
Not published

New since report 3

4 changes

Public report 3 of November 12, 2026, compared with report 2 of August 13, 2026

Compare report 2 and report 3

New

  • Estate debts

    €41,732.15

Changed

  • Preferential claims

    €2,781 €77,578.08

  • Estate account balance

    €60,199.15 €65,959.48

  • Hours spent

    57 h 12 min 62 h 18 min

Unchanged / ongoing

Estate assets Fin. report 3
€66,878.38, history of Estate assets

+€5,767.93 since financial report 2

Unsecured claims Report 3
€918.39, history of Unsecured claims

unchanged

Preferential Report 3
€77,578.08, history of Preferential

+€74,797.08 since report 2

Creditors Report 3
1, history of Creditors

unchanged

Employees Report 3
4, history of Employees

unchanged

Further case information

Status

Rent and lease
Mentioned Rent and lease
Staff
Mentioned Staff
Sale of assets
Mentioned Sale of assets
Collection of receivables
Mentioned Collection of receivables
Security rights
Mentioned Security rights
Restart (going-concern sale)
Mentioned Restart (going-concern sale)
Bookkeeping obligation
Mentioned Bookkeeping obligation
Filing of annual accounts
Mentioned Filing of annual accounts
Director liability
Mentioned Director liability
Actio pauliana
Under investigation Actio pauliana
Legal proceedings
Ongoing Legal proceedings
Lawfulness investigation
Under investigation Lawfulness investigation

Recent timeline

  1. Public financial report of November 12, 2026 published

  2. Public report of November 12, 2026 published

Key documents

  • Financieel verslag 12-11-2026

    11-12-2026 10 p. Rechtspraak

    View
  • Verslag: 12-11-2026

    11-12-2026 16 p. Rechtspraak

    View
  • Verslag: 13-08-2026

    08-13-2026 14 p. Rechtspraak

    View
  • Financieel verslag 13-08-2026

    08-13-2026 10 p. Rechtspraak

    View

Frequently asked questions about Future Genomics Technologies B.V.

Who has been appointed bankruptcy trustee of Future Genomics Technologies B.V.?

mr. A.J.M. van Winden of La Gro B.V. has been appointed bankruptcy trustee by the Rechtbank Den Haag. The bankruptcy trustee is the point of contact for questions about the bankruptcy.

When was Future Genomics Technologies B.V. declared bankrupt?

On April 14, 2026, Future Genomics Technologies B.V. was declared bankrupt by the Rechtbank Den Haag. The insolvency number of the case is F.09/26/121.

Where do I submit my claim against Future Genomics Technologies B.V.?

Send your claim in writing to the insolvency practitioner, mr. A.J.M. van Winden of La Gro B.V., with the documents that support it, such as invoices and contracts. Please state insolvency number F.09/26/121.

What does the bankruptcy of Future Genomics Technologies B.V. mean for creditors?

Through the bankruptcy the company loses control of its assets. Control passes to the insolvency practitioner, who sells the assets and distributes the proceeds among the creditors in the statutory ranking. Only at the end is it usually clear whether ordinary creditors receive anything, and how much.

How do I read the reports on the bankruptcy?

So far 3 public reports have appeared, the latest on November 12, 2026. They are under Reports in this case.

Company details

Legal form
BV
Trade names
FG-tech, FG-technologies

Sources

Not known: founded, kvk registration

Addresses

  • Correspondence address Trading address
    Postbus 1336 2302 BH Leiden
  • Business address Trading address
    Sylviusweg 74 2333 BE Leiden
    • Built in 2018
    • gezondheidszorgfunctie
    • kantoorfunctie
    • 2888 m²